Lushang Freda Pharmaceutical Co.,Ltd. (SHA:600223)

Market Cap	7.39B +3.6%
Revenue (ttm)	3.78B -5.3%
Net Income	214.11M -9.5%
EPS	0.21 -12.0%
Shares Out	1.02B
PE Ratio	34.60
Forward PE	26.93
Dividend	0.12 (1.65%)
Ex-Dividend Date	n/a

Volume	14,773,800
Average Volume	13,096,730
Open	7.40
Previous Close	7.42
Day's Range	7.26 - 7.41
52-Week Range	6.70 - 9.42
Beta	1.40
RSI	37.61
Earnings Date	Apr 3, 2026

About SHA:600223

Lushang Freda Pharmaceutical Co.,Ltd. engages in the production and sales of pharmaceuticals, raw materials, and additives in China. The company is involved in cosmetics and medicine businesses. It provides cleansers, lotions, creams, essences, masks, and other products. In addition, the company offers dermatology, orthopedics, ophthalmology, gynecology, and pediatrics, and accelerates project research and investigation areas. Further, it serves hospitals, pharmacies, primary medical institutions, and chain drug stores, etc. The company was for...

• Industry: Real Estate - Development
• Sector: Real Estate
• Founded: 1993
• Employees: 3,630
• Stock Exchange: Shanghai Stock Exchange
• Ticker Symbol: 600223

Financial Performance

In 2024, SHA:600223's revenue was 3.98 billion, a decrease of -13.02% compared to the previous year's 4.58 billion. Earnings were 243.53 million, a decrease of -19.73%.